نتایج جستجو برای: tg dtg

تعداد نتایج: 20768  

Journal: :AIDS 2014
Maureen Oliveira Thibault Mesplède Peter K Quashie Daniela Moïsi Mark A Wainberg

OBJECTIVE Among 1222 antiretroviral-naive patients who received dolutegravir (DTG) as part of first-line therapy, none has developed resistance against this compound after 48-96 weeks of follow-up. Moreover, only four occurrences of virological failure with resistance mutations have been documented in previously drug-experienced patients who received DTG as a first time integrase inhibitor as a...

Journal: :AIDS 2011
Sherene Min Louis Sloan Edwin DeJesus Trevor Hawkins Lewis McCurdy Ivy Song Richard Stroder Shuguang Chen Mark Underwood Tamio Fujiwara Stephen Piscitelli Jay Lalezari

OBJECTIVE To evaluate the antiviral activity, safety, pharmacokinetics, and pharmacokinetics/pharmacodynamics of dolutegravir (DTG), a next-generation HIV integrase inhibitor (INI), as short-term monotherapy. DESIGN A phase IIa, randomized, double-blind, dose-ranging study. METHODS In this study, INI-naive, HIV-1-infected adults currently off antiretroviral therapy were randomized to receiv...

Journal: :The Journal of pharmacology and experimental therapeutics 2013
Adam A Behensky Michelle Cortes-Salva Michael J Seminerio Rae R Matsumoto Jon C Antilla Javier Cuevas

Currently, the only Food and Drug Administration-approved treatment of acute stroke is recombinant tissue plasminogen activator, which must be administered within 6 hours after stroke onset. The pan-selective σ-receptor agonist N,N'-di-o-tolyl-guanidine (o-DTG) has been shown to reduce infarct volume in rats after middle cerebral artery occlusion, even when administered 24 hours after stroke. D...

2017
José M. Gatell Lambert Assoumou Graeme Moyle Laura Waters Margaret Johnson Pere Domingo Julie Fox Esteban Martinez Hans–Jürgen Stellbrink Giovanni Guaraldi Mar Masia Mark Gompels Stephane De Wit Eric Florence Stefan Esser François Raffi Anton L. Pozniak

OBJECTIVE To compare the efficacy, safety, and impact on lipid fractions of switching from a ritonavir-boosted protease inhibitor (PI/r) to a dolutegravir (DTG) regimen. METHODS HIV type 1-infected adults more than 50 years or with a Framingham score more than 10% were eligible if plasma HIV RNA less than 50 copies per ml for at least 24 weeks while on a PI/r regimen. Patients were randomized...

2016
Ying Gao Bo Yu Ke Wu Qiaoxia Yuan Xianhua Wang Hanping Chen

Effects of the type of biomass and temperature, with longer residence time, on physicochemical characteristics of hydrochar were investigated. Different carbonization conditions were applied with the goal of producing hydrochars having better physicochemical properties. After the carbonization process, the pyrolysis and combustion behaviors of hydrochar were evaluated. The effect of temperature...

Journal: :IOP conference series 2023

Abstract The object of the study is cement compositions based on white Portland cement, characterized by a high content marble powder and low water-to-cement ratio. samples were prepared with different concentrations components, affecting their densities strengths determined at 28 days or 120 curing. IR spectroscopy scanning electron microscopy supplement thermal analysis (heating rate 10°C/min...

2014
Jahamunna A. A. Barbosa Ariana Zoppi Mario A. Quevedo Polyanne N. de Melo Arthur S. A. de Medeiros Letícia Streck Alice R. de Oliveira Matheus F. Fernandes-Pedrosa Marcela R. Longhi Arnóbio A. da Silva-Júnior

The interaction of methotrexate (MTX) with beta-cyclodextrin (β-CD) in the presence of triethanolamine (TEA) was investigated with the aim to elucidate the mechanism whereby self-assembly cyclodextrin systems work in association with this third component. Solubility diagram studies showed synergic increment of the MTX solubility to be about thirty-fold. Experiments using 2D ROESY and molecular ...

Journal: :Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 2015
Arafa A M Belal M A Zayed M El-Desawy Sh M A H Rakha

Three Schiff's bases AI (2(1-hydrazonoethyl)phenol), AII (2, 4-dibromo 6-(hydrazonomethyl)phenol) and AIII (2(hydrazonomethyl)phenol) were prepared as new hydrazone compounds via condensation reactions with molar ratio (1:1) of reactants. Firstly by reaction of 2-hydroxy acetophenone solution and hydrazine hydrate; it gives AI. Secondly condensation between 3,5-dibromo-salicylaldehyde and hydra...

2013
Mark A Wainberg Thibault Mesplède Francois Raffi

BACKGROUND The HIV integrase inhibitor, Dolutegravir (DTG), was recently approved by the Food and Drug Administration in the United States and is the only HIV drug that has not selected for resistance mutations in the clinic when used as part of first-line therapy. This has led to speculation that DTG might have a higher genetic barrier for the development of drug resistance than the other comp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید